Both in Pharmaceuticals
Clene vs Annovis Bio
Over the past year CLNN returned −31.6% and ANVS returned −36.3%; their daily moves had a correlation of 0.20.
CLNN −31.6% ANVS −36.3%Growth of $1, one year, split-adjusted
| Metric | CLNN | ANVS |
|---|---|---|
| Price | $4.10 | $1.30 |
| Market cap | $58.3M | $55.5M |
| Today | +0.99% | −5.80% |
| 1 month | −3.1% | −24.4% |
| 6 months | −14.9% | −35.3% |
| Year to date | −30.2% | −62.4% |
| 1 year | −30.3% | −34.0% |
| Revenue growth (YoY) | +233.3% | — |
| Gross margin | 60.0% | — |
| Net margin | −14915.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 295.8× | — |
| Net cash | -$9.1M | $18.7M |
| Dividend yield | — | — |
| Volatility (60d) | 79.3% | 71.5% |
| Short % of float | 11.1% | 19.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).